Twist Bioscience (TWST) Retained Earnings (2018 - 2026)
Twist Bioscience has reported Retained Earnings over the past 9 years, most recently at -$1.4 billion for Q1 2026.
- Quarterly Retained Earnings fell 210490.03% to -$1.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.4 billion through Mar 2026, down 210490.03% year-over-year, with the annual reading at -$627000.0 for FY2025, 99.95% up from the prior year.
- Retained Earnings was -$1.4 billion for Q1 2026 at Twist Bioscience, down from -$1.4 billion in the prior quarter.
- Over five years, Retained Earnings peaked at -$609000.0 in Q4 2022 and troughed at -$1.4 billion in Q1 2026.
- The 5-year median for Retained Earnings is -$1.0 billion (2023), against an average of -$789.3 million.
- Year-over-year, Retained Earnings surged 99.95% in 2025 and then plummeted 210490.03% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$609000.0 in 2022, then plummeted by 176614.29% to -$1.1 billion in 2023, then decreased by 18.33% to -$1.3 billion in 2024, then dropped by 6.01% to -$1.4 billion in 2025, then fell by 3.26% to -$1.4 billion in 2026.
- Per Business Quant, the three most recent readings for TWST's Retained Earnings are -$1.4 billion (Q1 2026), -$1.4 billion (Q4 2025), and -$627000.0 (Q3 2025).